Emblica Officinalis: A Traditional Indian Herb
Emblica officinalis, a famous Indian herb commonly known as amala, became more popular during the COVID era. It is one of the most useful medicinal plants in classical Indian science, i.e., ayurveda. Its common popular synonym is Dhatri or Anurse, which means it cares for the person as a mother care for her child. Emblica officinalis has both nutritional and medicinal values. It is one of the herbs with the richest source of vitamin C. Even though its fruit comes in the category of minor fruit, it is very popular not only among farmers and nurserymen but also among ayurvedic physicians and even among scientists because of its increasing demand, especially during COVID, also due to its commercial significance, which is highly remunerative, because it does not require much care.
The Emblica officinalis syn. Phyllanthus emblica, or Indian gooseberry, comes in the category of minor arid zone fruit, which is a crop of commercial significance.
Zhang LZ, Zhao WH, Guo YJ, Tu GZ, Lin S, Xin LG, Studies on chemical constituents in fruits of Tibetan medicine Phyllanthus emblica, Zhongguo Zhong Yao ZaZhi.2003; 28(10): 940-3.
Udupa KN, Ayurveda for Promotion of Health, Journal of Ayurveda, 3, 1985.
Sharma SK, James B, Perianayagam, Aney Joseph AJM, Christina, Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn, Journal of Ethnopharmacology. 2004; 95,83-5.
Nosal ova G, Mokry J, Hasan KM, Antitussive activity of the fruit extract of Emblica officinalis Gaertn, (Euphorbiaceae), Phytomedicine 2003;10,583-9.
Santoshkumar J, Manjunath S, Pranavkumar MS, A study of antihyperlipidemia, hypolipedimic and antiatherogenic activity of fruit of Emblica officinalis (Amla) in high fat fed Albino Rats, International Journal of Medical Research and Health Sciences. 2013;2(1): 70-77.
Agnivesha, Charaka samhita, elaborated by Charak and Dradhbala with Ayurveddeepika commentary by Shri Chakrapanidutta, Edited by: Vaidya Yadavji trikamji acharya, Prolouged by: Prof. R.H.Shingh Published by: Chaukhambha Subharati Prakashan Reprinted 2011
Vr i d h h a S u s h r u ta , A c h a r ya S u s h r u ta , Nagarjuna,Chandrat, Sushruta Samhita, With commentary Nibandhsangraha of Dalhanacharya, edited by Acharya yadavaji trikamji, Reprint, Chaukhambha surbharti Prakashan,Varanasi, 2008.
Kim HJ,Yokozawa T, Kim HY,Tohda C, Rao TP, Juneja LR.Influence of Amla (EmblicaofficinalisGaertn.) on Hypercholestremia and Lipid Peroxidation in Biological Membranes. J. Ethanopharmocol.2005; 64(2): 135-139.
Calixto JB, Santos AR, Cechinel-Filho V& Yunes RA. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology and therapeutic potential. Medicinal Research Reviews.1998; 18(4): 225–258.
Dey KL, The Indigenous Drugs of India - Short Descriptive Notices of the Principal Medicinal Plants Met with in British India, 2nd edition. Thacker, Spink & Co., Calcutta, 1896.
How to Cite
Copyright (c) 2023 Journal of Drug Discovery and Development ( ISSN:2581-6861)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.